Dr. Alex Aliper, Co-Founder and President of Insilico Medicine, has been invited to attend the Riyadh Global Medical Biotechnology Summit (RGMBS) 2026 from September 14 to 16. (IMAGE)

InSilico Medicine

Dr. Alex Aliper, Co-Founder and President of Insilico Medicine, has been invited to attend the Riyadh Global Medical Biotechnology Summit (RGMBS) 2026 from September 14 to 16.

Caption

On September 16 (09:00-12:00), at the Sofitel Riyadh Hotel & Convention Center, Dr. Aliper will lead the Insilico team in hosting a hands-on workshop titled "Model Context Protocol (MCP)-Empowered Protein Design: Combining AI Foundation Models and Physics-Based Molecular Modelling". Participants will gain first-hand experience using MCP to connect AI foundation models, molecular simulation and databases; master the complete workflow from structure preparation to physics-based validation; learn how to score and prioritize drug candidates with AlphaFold, RDKit and OpenMM; interpret binding modes, kinetics and free-energy calculation results; and run a directed MCP workflow inside the Chemistry42 sandbox.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.